Regulatory News
Monday, June 13, 2016
BRIEF-Revance reports results for RT001 topical Phase 3 trial for lateral canthal lines
* Revance reports results for RT001 topical Phase 3 trial
for lateral canthal lines
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment